Valuation : LeMaitre Vascular, Inc.

Market Cap 1.84B 1.59B 1.5B 1.36B 2.56B 176B 2.57B 17.86B 6.87B 89.58B 6.92B 6.77B 283B P/E 2026 *
28.1x
P/E 2027 * 25.4x
Enterprise Value 1.6B 1.38B 1.31B 1.19B 2.22B 153B 2.23B 15.53B 5.97B 77.89B 6.02B 5.89B 246B EV / Sales 2026 *
5.79x
EV / Sales 2027 * 5.09x
Free-Float
87.26%
Yield 2026 *
1.24%
Yield 2027 * 1.39%
1 day-0.74%
1 week-1.46%
Current month-1.46%
1 month-2.88%
3 months-15.09%
6 months-28.19%
Current year-3.57%
1 week 66
Extreme 66
68.5
1 month 66
Extreme 66
71
Current year 66
Extreme 66
99
1 year 66
Extreme 66
99
3 years 42
Extreme 42
102
5 years 35.4
Extreme 35.4
102
10 years 19.1
Extreme 19.1
102
Manager TitleAgeSince
Chief Executive Officer 61 31/05/1992
Director of Finance/CFO 51 09/03/2025
Director of Finance/CFO 62 31/12/1999
Director TitleAgeSince
Director/Board Member 68 31/12/2002
Chairman 61 31/12/2003
Director/Board Member 61 23/10/2016
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-1.46% - - 1.84B
+1.10%-0.65%+24.10%+18.43% 225B
-0.19%-3.62%+2.55%-20.00% 141B
+2.41%+0.67%-19.02%+22.09% 130B
-0.28%-10.08%-58.81%-21.22% 62.29B
-2.77%-6.15%+8.15%+12.69% 48.63B
-0.49%-1.97%-20.35%-15.53% 49.39B
+2.66%-2.61%+15.94%+29.91% 41.42B
+1.67%-0.25%+35.01%+55.09% 40.12B
-0.60%-4.41%-20.52%+44.06% 31.23B
Average +0.28%-3.42%-3.66%+13.95% 85.52B
Weighted average by Cap. +0.52%-2.50%+0.60%+9.84%

Financials

2026 *2027 *
Net sales 277M 238M 226M 204M 384M 26.42B 386M 2.68B 1.03B 13.44B 1.04B 1.02B 42.47B 303M 261M 247M 224M 420M 28.94B 422M 2.94B 1.13B 14.72B 1.14B 1.11B 46.52B
Net income 66.71M 57.48M 54.43M 49.33M 92.55M 6.37B 93.02M 646M 249M 3.24B 251M 245M 10.25B 74.29M 64.01M 60.61M 54.93M 103M 7.1B 104M 720M 277M 3.61B 279M 273M 11.41B
Net Debt -240M -207M -196M -178M -334M -22.98B -335M -2.33B -896M -11.69B -903M -883M -36.94B -300M -259M -245M -222M -417M -28.7B -419M -2.91B -1.12B -14.6B -1.13B -1.1B -46.14B
Logo LeMaitre Vascular, Inc.
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser degree, other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which are used in open vascular surgery and dialysis access. It offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold globally in the United States, Europe, Canada and Asia Pacific.
Employees
651
Date Price Change
11/09/26 €67.50 -0.74%
10/09/26 €68.00 +3.03%
09/09/26 €66.00 -0.75%
08/09/26 €66.50 -2.92%
07/09/26 €68.50 0.00%
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
80.59USD
Average target price
107.00USD
Spread / Average Target
+32.77%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!